Cargando…

Association study between drug prescriptions and Alzheimer’s disease claims in a commercial insurance database

In the ongoing effort to discover treatments for Alzheimer’s disease (AD), there has been considerable focus on investigating the use of repurposed drug candidates. Mining of electronic health record data has the potential to identify novel correlated effects between commonly used drugs and AD. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Eric, Li, Tong Shu, Wineinger, Nathan E., Su, Andrew I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290352/
https://www.ncbi.nlm.nih.gov/pubmed/37355615
http://dx.doi.org/10.1186/s13195-023-01255-0
_version_ 1785062477099171840
author Hu, Eric
Li, Tong Shu
Wineinger, Nathan E.
Su, Andrew I.
author_facet Hu, Eric
Li, Tong Shu
Wineinger, Nathan E.
Su, Andrew I.
author_sort Hu, Eric
collection PubMed
description In the ongoing effort to discover treatments for Alzheimer’s disease (AD), there has been considerable focus on investigating the use of repurposed drug candidates. Mining of electronic health record data has the potential to identify novel correlated effects between commonly used drugs and AD. In this study, claims from members with commercial health insurance coverage were analyzed to determine the correlation between the use of various drugs on AD incidence and claim frequency. We found that, within the insured population, several medications for psychotic and mental illnesses were associated with higher disease incidence and frequency, while, to a lesser extent, antibiotics and anti-inflammatory drugs were associated with lower AD incidence rates. The observations thus provide a general overview of the prescription and claim relationships between various drug types and Alzheimer’s disease, with insights into which drugs have possible implications on resulting AD diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01255-0.
format Online
Article
Text
id pubmed-10290352
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102903522023-06-25 Association study between drug prescriptions and Alzheimer’s disease claims in a commercial insurance database Hu, Eric Li, Tong Shu Wineinger, Nathan E. Su, Andrew I. Alzheimers Res Ther Research In the ongoing effort to discover treatments for Alzheimer’s disease (AD), there has been considerable focus on investigating the use of repurposed drug candidates. Mining of electronic health record data has the potential to identify novel correlated effects between commonly used drugs and AD. In this study, claims from members with commercial health insurance coverage were analyzed to determine the correlation between the use of various drugs on AD incidence and claim frequency. We found that, within the insured population, several medications for psychotic and mental illnesses were associated with higher disease incidence and frequency, while, to a lesser extent, antibiotics and anti-inflammatory drugs were associated with lower AD incidence rates. The observations thus provide a general overview of the prescription and claim relationships between various drug types and Alzheimer’s disease, with insights into which drugs have possible implications on resulting AD diagnosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01255-0. BioMed Central 2023-06-24 /pmc/articles/PMC10290352/ /pubmed/37355615 http://dx.doi.org/10.1186/s13195-023-01255-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hu, Eric
Li, Tong Shu
Wineinger, Nathan E.
Su, Andrew I.
Association study between drug prescriptions and Alzheimer’s disease claims in a commercial insurance database
title Association study between drug prescriptions and Alzheimer’s disease claims in a commercial insurance database
title_full Association study between drug prescriptions and Alzheimer’s disease claims in a commercial insurance database
title_fullStr Association study between drug prescriptions and Alzheimer’s disease claims in a commercial insurance database
title_full_unstemmed Association study between drug prescriptions and Alzheimer’s disease claims in a commercial insurance database
title_short Association study between drug prescriptions and Alzheimer’s disease claims in a commercial insurance database
title_sort association study between drug prescriptions and alzheimer’s disease claims in a commercial insurance database
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290352/
https://www.ncbi.nlm.nih.gov/pubmed/37355615
http://dx.doi.org/10.1186/s13195-023-01255-0
work_keys_str_mv AT hueric associationstudybetweendrugprescriptionsandalzheimersdiseaseclaimsinacommercialinsurancedatabase
AT litongshu associationstudybetweendrugprescriptionsandalzheimersdiseaseclaimsinacommercialinsurancedatabase
AT wineingernathane associationstudybetweendrugprescriptionsandalzheimersdiseaseclaimsinacommercialinsurancedatabase
AT suandrewi associationstudybetweendrugprescriptionsandalzheimersdiseaseclaimsinacommercialinsurancedatabase